Microvast (MVST) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Achieved record Q2 2025 revenue of $91.3 million, up 9.2% year-over-year, with gross margin rising to 34.7% from 32.5%.
Six-month revenue reached $207.8 million, a 25.9% increase year-over-year, with gross margin improving to 36.0% from 26.9%.
Reported GAAP net loss of $106.1 million for Q2, primarily due to a $121.5 million loss from changes in fair value of a convertible loan, but delivered positive adjusted EBITDA of $25.9 million and adjusted net profit of $16.3 million.
Order backlog stood at $320 million, reflecting strong market demand and execution, with most orders expected to be fulfilled in 2025 and 2026.
Continuous innovation in battery technology, including launch of ME6 LFP-based system and advancements in silicon-based and all-solid-state batteries.
Financial highlights
Q2 gross profit reached $31.7 million, a 17% increase year-over-year; six-month gross profit was $74.7 million, up 68%.
Adjusted EBITDA for Q2 was $25.9 million, with year-to-date adjusted EBITDA at $54.4 million.
Adjusted net profit for Q2 was $16.3 million, a turnaround from an adjusted net loss of $87.9 million last year; six-month adjusted net profit was $35.6 million.
Operating expenses dropped 87% year-over-year to $16.5 million in Q2, mainly due to reduced share-based compensation and prior year impairments; first half operating expenses decreased 74.9% to $42.0 million.
Cash, cash equivalents, and restricted cash totaled $138.8 million at quarter's end, with net cash from operating activities of $44.3 million for the first half.
Outlook and guidance
Full-year 2025 revenue guidance maintained at $450–$475 million, representing 18–25% growth.
Gross margin target updated to 32% for the year, focusing on higher margin products and regional efficiencies.
Anticipates continued strong growth in EMEA and APAC, with new capacity from Huzhou Phase 3.2 expansion coming online by year-end.
Management expects continued positive operating cash flow and profitability, supported by a strong order backlog and stable gross margins.
Additional financing is needed to complete the Clarksville, Tennessee facility and support further U.S. expansion.
Latest events from Microvast
- Q2 revenue up 12% to $83.7M, EMEA surged, but net loss widened on impairment and liquidity risks.MVST
Q2 20241 Feb 2026 - Q3 profit and 27% revenue growth driven by EMEA, but liquidity and expansion risks persist.MVST
Q3 202414 Jan 2026 - Record revenue, margin gains, and $401M backlog support strong 2025 growth outlook.MVST
Q4 202426 Dec 2025 - Offering up to $250M in securities to support growth in U.S. battery technology and production.MVST
Registration Filing16 Dec 2025 - Up to $250M in securities offered; major stockholder may sell 5.5M shares; broad risk factors disclosed.MVST
Registration Filing16 Dec 2025 - Annual meeting to elect directors, ratify auditor, and address governance and compliance.MVST
Proxy Filing1 Dec 2025 - Virtual meeting to elect director, ratify auditor, and address governance and compensation.MVST
Proxy Filing1 Dec 2025 - Virtual annual meeting to elect directors and ratify Deloitte as auditor for 2024.MVST
Proxy Filing1 Dec 2025 - Record Q1 revenue and profit, strong outlook, but liquidity and litigation risks persist.MVST
Q1 202525 Nov 2025